Daniel Kim to Immunotherapy
This is a "connection" page, showing publications Daniel Kim has written about Immunotherapy.
Connection Strength
0.093
-
Pan CX, Liu M, Lau CB, Lau WC, Kim DY, Saberi SA, Rowley R, Kanwar R, Giobbie-Hurder A, LeBoeuf NR, Nambudiri VE. Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors. J Am Acad Dermatol. 2024 04; 90(4):826-829.
Score: 0.047
-
Pan CX, Lau WC, Kim DY, Lau CB, Rowley R, Kanwar R, LeBoeuf NR, Nambudiri VE. Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation. J Am Acad Dermatol. 2023 12; 89(6):1264-1268.
Score: 0.046